Amended Current Report Filing (8-k/a)
September 11 2019 - 2:30PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K/A
(Amendment No. 1)
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act
of 1934
Date of
Report (Date of earliest event reported)
July 17, 2019
AEHR TEST SYSTEMS
(Exact
name of registrant as specified in its charter)
California
|
|
000-22893
|
|
94-2424084
|
(State
or other jurisdiction of incorporation)
|
|
(Commission
File Number)
|
|
(IRS
Employer
Identification
No.)
|
|
400 KATO TERRACE,
FREMONT, CA 94539
|
(Address
of principal executive offices, including zip code)
|
|
510-623-9400
|
(Registrant’s
telephone number, including area code)
|
|
N/A
|
(Former
name or former address, if changed since last report)
|
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
☐
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
Indicate by check
mark whether the registrant is an emerging growth company as
defined in Rule 405 of the Securities Act of 1933 (§230.405 of
this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934
(§240.12b-2 of this chapter).
Emerging growth
company ☐
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange Act. ☐
Securities
registered pursuant to Section 12(b) of the Act:
|
Trading
|
|
Title of each
class
|
Symbol(s)
|
Name of each
exchange on which registered
|
Common
Stock
|
AEHR
|
The
NASDAQ Capital Market
|
Explanatory Note
Aehr
Test Systems (the “Company”) filed with the Securities
and Exchange Commission (the “SEC”) on July 19, 2019 a
Current Report on Form 8-K (the “Original Filing”) to
disclose that the Company’s board of directors (the
“Board”) increased the size of the Board by one
director, from six to seven directors, and appointed Laura Oliphant
to the Board. At the time of the Original Filing, the Board had not
determined to which committees, if any, Ms. Oliphant would be
appointed.
Item 5.02. Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
(d)
Pursuant to Instruction 2 to Item 5.02 of Form 8-K, the Company is
filing this Amendment No. 1 on Form 8-K/A to amend the Original
Filing to disclose that, on September 9, 2019, the Board appointed
Ms. Oliphant to serve on the Audit Committee of the Board and the
Compensation Committee of the Board. Except as stated herein, the
Original Filing shall remain in effect.
Item 5.03. Amendments to Articles of Incorporation or Bylaws;
Change in Fiscal Year.
(a)
In addition, the Company clarifies that the increase in the size of
the Board by one director, from six to seven directors, was
effected by an amendment to Section 3.2 of Article III of the
Company’s bylaws (the “Bylaws”) to change the
exact number of directors from six to seven. The amendment to the
Bylaws was effective as of July 16, 2019. The foregoing description
of the amendment to the Bylaws does not purport to be complete and
is qualified in its entirety by reference to the Bylaws, which are
attached as Exhibit 3.2 to the Company’s Annual Report on
Form 10-K for the fiscal year ended May 31, 2019 filed with the SEC
on August 28, 2019 and are incorporated herein by
reference.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
Aehr
Test Systems
(Registrant)
|
|
|
|
|
|
Date:
September 11, 2019
|
By:
|
/s/
Kenneth B. Spink
|
|
|
|
Kenneth
B. Spink
|
|
|
|
Vice
President of Finance and
Chief
Financial Officer
|
|
Aehr Test Systems (NASDAQ:AEHR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aehr Test Systems (NASDAQ:AEHR)
Historical Stock Chart
From Sep 2023 to Sep 2024